128 related articles for article (PubMed ID: 11727693)
1. Falsely elevated serum digoxin levels secondary to endogenous digoxin-like immunoreactive substances.
Koobatian TJ; Roberts JR
Acad Emerg Med; 1995 Apr; 2(4):322-6. PubMed ID: 11727693
[TBL] [Abstract][Full Text] [Related]
2. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
Greenway DC; Nanji AA
Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
[TBL] [Abstract][Full Text] [Related]
3. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
Dasgupta A
Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
[TBL] [Abstract][Full Text] [Related]
4. Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay.
Dasgupta A; Nakamura A; Doria L; Dennen D
Clin Chem; 1989 Feb; 35(2):323-4. PubMed ID: 2914387
[No Abstract] [Full Text] [Related]
5. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
Li JH; Wu ZG; Xu JQ; Zhou Y
Yao Xue Xue Bao; 1997; 32(3):174-7. PubMed ID: 11327016
[TBL] [Abstract][Full Text] [Related]
6. Effect of incubation time and temperature on the interference of digoxin-like immunoreactive substances in digoxin immunoassays.
Yannakou L; Diamandis EP; Souvatzoglou A
Ther Drug Monit; 1987 Dec; 9(4):461-3. PubMed ID: 3424414
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of digoxin: impact of endogenous and exogenous digoxin-like immunoreactive substances.
Dasgupta A
Toxicol Rev; 2006; 25(4):273-81. PubMed ID: 17288498
[TBL] [Abstract][Full Text] [Related]
8. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
Seccombe DW; Pudek MR; Humphries KH
J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
[TBL] [Abstract][Full Text] [Related]
9. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
Scherrmann JM; Sandouk P; Guedeney X
Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
[TBL] [Abstract][Full Text] [Related]
10. [Determination of digoxin-like immunoreactive substances in sera of 15 elder patients with cardiac insufficiency].
Li J; Wu Z; Xu J; Zhou Y; Chu X
Yao Xue Xue Bao; 1998 Sep; 33(9):655-8. PubMed ID: 12016868
[TBL] [Abstract][Full Text] [Related]
11. Digoxin-like immunoreactive substance (DLIS) in liver disease: comparison of clinical and laboratory parameters in patients with and without DLIS.
Gervais A; Nanji AA; Greenway DC; McLean W
Drug Intell Clin Pharm; 1987 May; 21(5):450-2. PubMed ID: 3582173
[TBL] [Abstract][Full Text] [Related]
12. Endogenous digitalis-like immunoreactive substances in cord serum characterized by anti-digitoxin and anti-digoxin antibodies. Effect of modulated incubation conditions.
Scherrmann JM; Sandouk P; Guedeney X
Clin Biochem; 1986 Aug; 19(4):201-4. PubMed ID: 3530526
[TBL] [Abstract][Full Text] [Related]
13. Digitalis-like immunoreactive substances in maternal and umbilical cord plasma: a comparative sensitivity study of fluorescence polarization immunoassay and microparticle enzyme immunoassay.
Ijiri Y; Hayashi T; Kamegai H; Ohi K; Suzuki K; Kitaura Y; Takenaka H
Ther Drug Monit; 2003 Apr; 25(2):234-9. PubMed ID: 12657920
[TBL] [Abstract][Full Text] [Related]
14. Effect of a Chinese medicine "kyushin" on serum digoxin concentration measurement in dogs.
Lin CS; Lin MC; Chen KS; Liu CB
Jpn Circ J; 1989 Feb; 53(2):108-12. PubMed ID: 2716172
[TBL] [Abstract][Full Text] [Related]
15. Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin.
Dasgupta A; Schammel DP; Limmany AC; Datta P
Ther Drug Monit; 1996 Feb; 18(1):34-9. PubMed ID: 8848818
[TBL] [Abstract][Full Text] [Related]
16. Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations.
Dasgupta A; Trejo O
Am J Clin Pathol; 1999 Mar; 111(3):406-10. PubMed ID: 10078117
[TBL] [Abstract][Full Text] [Related]
17. Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations.
Wu SL; Li W; Wells A; Dasgupta A
Am J Clin Pathol; 2001 Apr; 115(4):600-4. PubMed ID: 11293909
[TBL] [Abstract][Full Text] [Related]
18. Interference of digoxin-like immunoreactive substances with three digoxin immunoassays in patients with various degrees of renal function.
Pleasants RA; Gadsden RH; McCormack JP; Piveral K; Sawyer WT
Clin Pharm; 1986 Oct; 5(10):810-6. PubMed ID: 3780148
[TBL] [Abstract][Full Text] [Related]
19. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit assay methods.
Morris RG; Frewin DB; Saccoia NC; Goldsworthy WL; Jeffries WS; McPhee AJ
Eur J Clin Pharmacol; 1990; 39(4):359-63. PubMed ID: 2076718
[TBL] [Abstract][Full Text] [Related]
20. Digoxin-like immunoreactive substance in the elderly patient and its impact on the TDx digoxin assay.
Yamamoto T; Takano K; Sanaka M; Nomura Y; Koike Y; Mineshita S
Ther Drug Monit; 1998 Aug; 20(4):417-21. PubMed ID: 9712467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
